MM

Mamoru Matsuda

SC Santen Pharmaceutical Co.: 15 patents #14 of 291Top 5%
Overall (All Time): #323,403 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
9062061 Compound having PARP inhibitory activity Takahiro Honda, Hiroshi Enomoto, Kenji Kawashima, Shinji TAKAOKA, Yasutaka Fujioka +4 more 2015-06-23
8975256 1,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activity Toshiyuki Mori, Kenji Kawashima, Minoru Yamamoto, Masatomo Kato, Miwa Takai +2 more 2015-03-10
8664221 Method for treating an inflammatory disease by administering a 1,2,3,4- tetrahydroquinoxaline compound containing a phenyl group having a sulfonic acid ester structure introduced therein as a substituent Masatomo Kato, Miwa Takai, Takahiro Matsuyama, Tatsuji Kurose, Yumi Hagiwara +2 more 2014-03-04
8580784 Method for treating a disease related to the glucocorticoid receptor Masato Nagatsuka, Toshiyuki Mori, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2013-11-12
8569493 Method for treating a homeostasis-related disease or glaucoma by administering a 1,2,3,4-tetrahyroquinoxaline compound Toshiyuki Mori, Masato Nagatsuka, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2013-10-29
8563551 Method for preventing or treating a disease related to the glucocorticoid receptor Masato Nagatsuka, Toshiyuki Mori, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2013-10-22
8551991 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity Toshiyuki Mori, Kenji Kawashima, Minoru Yamamoto, Masatomo Kato, Miwa Takai +2 more 2013-10-08
8440660 Method for treating a disease related to the glucocorticoid receptor Masato Nagatsuka, Toshiyuki Mori, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2013-05-14
8426406 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group Masatomo Kato, Miwa Takai, Takahiro Matsuyama, Tatsuji Kurose, Yumi Hagiwara +3 more 2013-04-23
8420635 Method for preventing or treating a glucocorticoid receptor-related disease Toshiyuki Mori, Kenji Kawashima, Masato Nagatsuka, Sachiko Kobayashi, Minoru Yamamoto +3 more 2013-04-16
8193187 1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity Toshiyuki Mori, Masato Nagatsuka, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2012-06-05
8017775 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity Toshiyuki Mori, Kenji Kawashima, Masato Nagatsuka, Sachiko Kobayashi, Minoru Yamamoto +3 more 2011-09-13
8008496 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents Masato Nagatsuka, Toshiyuki Mori, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2011-08-30
8008497 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents Masato Nagatsuka, Toshiyuki Mori, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2011-08-30
8008498 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents Masato Nagatsuka, Toshiyuki Mori, Sachiko Kobayashi, Masatomo Kato, Miwa Takai 2011-08-30